Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.1 Indenture
- 4.2 Registration Rights Agreement
- 4.3 Purchase Agreement
- 5 Opinion Letter of Quarles & Brady LLP
- 12 Computation of Ratio of Earnings to Fixed Charges
- 21 Subsidiaries of the Registrant
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Earnst & Young LLP
- 25 Statement of Eligibility on Form T-1
- 99.1 Letter of Transmittal
- 99.2 Notice of Guaranteed Delivery
Apogent Finance similar filings
- 17 Oct 03 Registration of securities issued in business combination transactions (amended)
- 25 Sep 03 Registration of securities issued in business combination transactions (amended)
- 28 Aug 03 Registration of securities issued in business combination transactions (amended)
- 16 Jul 03 Registration of securities issued in business combination transactions
- 2 Jul 01 Registration of securities issued in business combination transactions (amended)
- 1 Jun 01 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
Consent of Independent Auditors
We consent to the reference to our firm under the caption “Experts” in the Registration Statement and related Prospectus of Apogent Technologies Inc. for the registration of $250,000,000 6.50% Senior Subordinated Notes due 2013 and to the incorporation by reference therein of our report dated June 5, 2002, with respect to the statements of The Dairy and Drugs of Abuse Testing Business of CV Holdings, LLC and CV Leasing LLC included in the Current Report on Form 8-K of Apogent Technologies Inc. dated December 18, 2002, as amended by Amendment No. 1 thereto on Form 8-K/A, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Syracuse, New York
July 11, 2003